For-profit organizations · Québec, Quebec
Biotechnologies Aramis inc.
- Total value
- $40.3M
- Agreements
- 4
- Programs
- 3
- First and latest
- 2024–2026
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
Applying for the same funding? NRC IRAP Financial Assistance (apply through the funder’s page; no deadline stated). Deadlines, who can apply and who else got it.
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| SIF Stream 1- R&DInnovation, Science and Economic Development Canada | Innovation, Science and Economic Development Canada | 1 | $40M |
| Industrial Research Assistance ProgramNational Research Council Canada | National Research Council Canada | 1 | $200K |
| Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | National Research Council Canada | 2 | $125K |
By year
Funding by the year agreements started.
* 2026 so far: agreements starting by Oct 2026. Departments publish each quarter after it ends, so the latest months fill in later.
Show the numbers
| Year | Agreements | Total |
|---|---|---|
| 2024 | 2 | $40.1M |
| 2025 | 1 | $50K |
| 2026* | 1 | $200K |
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Industrial Research Assistance ProgramNational Research Council CanadaProduction of bioactive molecules using a plant-based bioproduction platform. · Contribution · National Research Council Canada · Apr 2026 | Production of bioactive molecules using a plant-based bioproduction platform.Contribution | $200,000 | |
| Industrial Research Assistance Program – Contributions to FirmsNational Research Council CanadaARP - Feasibility: Evaluation of a production platform in plants for the expression of Artificial Intelligence (AI)-enhanced antibodies for the treatment of various cancers. · Contribution · National Research Council Canada · Feb 2025 | ARP - Feasibility: Evaluation of a production platform in plants for the expression of Artificial Intelligence (AI)-enhanced antibodies for the treatment of various cancers.Contribution | $50,000 | |
| SIF Stream 1- R&DInnovation, Science and Economic Development CanadaContribution · Innovation, Science and Economic Development Canada · May 2024 | Contribution | $40,000,000 | |
| Industrial Research Assistance Program – Contributions to FirmsNational Research Council CanadaARP— Feasibility—Development of a plant production system in a closed environment for the production of recombinant vaccines. · Contribution · National Research Council Canada · Feb 2024 | ARP— Feasibility—Development of a plant production system in a closed environment for the production of recombinant vaccines.Contribution | $75,000 |